Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 8, Pages 2012-2017
Publisher
Proceedings of the National Academy of Sciences
Online
2017-02-07
DOI
10.1073/pnas.1615413114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke
- (2016) Melissa A. Lopes Pinheiro et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia
- (2016) Maryam Nazari et al. BRAIN RESEARCH BULLETIN
- Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems
- (2016) Luke Healy et al. CURRENT DRUG TARGETS
- Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation
- (2016) Hsing-Chuan Tsai et al. DRUGS
- The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures
- (2016) Catherine O’Sullivan et al. Journal of Neuroinflammation
- Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis
- (2016) Mauricio F. Farez et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
- (2016) Veit Rothhammer et al. NATURE MEDICINE
- Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments
- (2016) Faik Imeri et al. NEUROPHARMACOLOGY
- The emerging role of FTY720 (Fingolimod) in cancer treatment
- (2016) Christopher White et al. Oncotarget
- Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis
- (2016) Ludwig Kappos et al. JAMA Neurology
- Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection
- (2016) Irina V. Tiper et al. Pathogens and Disease
- Astrocyte pathology in Alexander disease causes a marked inflammatory environment
- (2015) Markel Olabarria et al. ACTA NEUROPATHOLOGICA
- MS565: A SPECT Tracer for Evaluating the Brain Penetration of BAF312 (Siponimod)
- (2015) Emmanuelle Briard et al. ChemMedChem
- Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
- (2015) Richard L. Proia et al. JOURNAL OF CLINICAL INVESTIGATION
- Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis
- (2015) Carine Savarin et al. Journal of Neuroinflammation
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Effect of FTY720-phosphate on the expression of inflammation-associated molecules in astrocytes in vitro
- (2015) STEFANIE JANSSEN et al. Molecular Medicine Reports
- Astrocyte barriers to neurotoxic inflammation
- (2015) Michael V. Sofroniew NATURE REVIEWS NEUROSCIENCE
- Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice
- (2015) H. Chen et al. NEUROSCIENCE
- Control of autoimmune CNS inflammation by astrocytes
- (2015) Veit Rothhammer et al. Seminars in Immunopathology
- Astrocytes Control Synapse Formation, Function, and Elimination
- (2015) Won-Suk Chung et al. Cold Spring Harbor Perspectives in Biology
- The Non-Obese Diabetic Mouse Strain as a Model to Study CD8+ T Cell Function in Relapsing and Progressive Multiple Sclerosis
- (2015) Prenitha Mercy Ignatius Arokia Doss et al. Frontiers in Immunology
- Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide
- (2014) Emanuela Colombo et al. ANNALS OF NEUROLOGY
- Mechanisms of white matter damage in multiple sclerosis
- (2014) Hans Lassmann GLIA
- Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond
- (2014) Christopher S. Garris et al. IMMUNOLOGY
- Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis
- (2014) Roy Y. Kim et al. JOURNAL OF NEUROIMMUNOLOGY
- Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE
- (2014) M. Moreno et al. JOURNAL OF NEUROSCIENCE
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Sphingolipid metabolites in inflammatory disease
- (2014) Michael Maceyka et al. NATURE
- Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
- (2014) Lior Mayo et al. NATURE MEDICINE
- Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model
- (2014) Daniel C. Anthony et al. NEUROPHARMACOLOGY
- Fingolimod for the treatment of neurological diseases—state of play and future perspectives
- (2014) Robert Brunkhorst et al. Frontiers in Cellular Neuroscience
- The astrocyte in multiple sclerosis revisited
- (2013) Celia F. Brosnan et al. GLIA
- FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats
- (2013) Masoumeh Asle-Rousta et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
- (2013) Celina Wu et al. Journal of Neuroinflammation
- Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
- (2013) Aran Groves et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
- (2013) Tobias Goldmann et al. NATURE NEUROSCIENCE
- Identification of a unique TGF-β–dependent molecular and functional signature in microglia
- (2013) Oleg Butovsky et al. NATURE NEUROSCIENCE
- White matter astrocytes in health and disease
- (2013) I. Lundgaard et al. NEUROSCIENCE
- Fingolimod Therapy for Multiple Sclerosis
- (2013) Mary Willis et al. SEMINARS IN NEUROLOGY
- Modeling the heterogeneity of multiple sclerosis in animals
- (2013) Sarah B. Simmons et al. TRENDS IN IMMUNOLOGY
- Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
- (2013) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
- (2013) G. K. Sheridan et al. Open Biology
- IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages
- (2012) Hui-Rong Jiang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- The initiation and prevention of multiple sclerosis
- (2012) Alberto Ascherio et al. Nature Reviews Neurology
- Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model
- (2011) Hye Jung Kim et al. FASEB JOURNAL
- S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures
- (2011) Graham K. Sheridan et al. GLIA
- Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
- (2011) Bahareh Ajami et al. NATURE NEUROSCIENCE
- Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy
- (2011) R. Hohlfeld et al. NEUROLOGY
- Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation
- (2011) T. Hla et al. NEUROLOGY
- Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
- (2011) M. Mehling et al. NEUROLOGY
- Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
- (2010) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (Fingolimod) in multiple sclerosis
- (2010) Chang Wook Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system
- (2009) Alexander Mildner et al. BRAIN
- FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
- (2009) Volker Brinkmann BRITISH JOURNAL OF PHARMACOLOGY
- Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
- (2009) Mauricio F Farez et al. NATURE IMMUNOLOGY
- FTY720 Rescue Therapy in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis: Expression of Central Nervous System Genes and Reversal of Blood-Brain-Barrier Damage
- (2008) Carolyn A. Foster et al. BRAIN PATHOLOGY
- Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis
- (2008) Alexandre S. Basso et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now